Baricitinib vs Montelukast

## Baricitinib vs Montelukast: Overview

This comparison examines the pharmacological differences between **Baricitinib** and **Montelukast**.

## Mechanism of Action

**Baricitinib**: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.

**Montelukast**: Selective leukotriene D4 receptor antagonist.

## Pharmacokinetics

**Half-life**: Baricitinib — 12 hours; Montelukast — 2.7-5.5 hours.

## Chemical Properties

**Molecular Formula**: Baricitinib — C16H17N7O2S; Montelukast — C35H36ClNO3S.

**Molecular Weight**: Baricitinib — 371.4170 g/mol; Montelukast — 586.1800 g/mol.

**Type**: Baricitinib — Small molecule; Montelukast — Small molecule.